Hikma to ease U.S. hydromorphone shortage; FDA gives nod to Terumo to boost anticoagulant stocks
admin 18th July 2018 Uncategorised 0Generics maker Hikma is looking to ease the U.S. shortage of hydromorphone with increased production as the FDA gave its OK to Terumo BCT to shore up short supplies of anticoagulant solution.
More: Hikma to ease U.S. hydromorphone shortage; FDA gives nod to Terumo to boost anticoagulant stocks
Source: fierce